Biotricity achieves market expansion in two new states
REDWOOD CITY, Calif., Mar. 27, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, has expanded its sales team…
Biotricity announces expanded R&D team for the development of its fetal/maternal and ambulatory wellness monitoring systems
REDWOOD CITY, Calif., Mar. 19, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to announce…
Biotricity achieves significant milestones for both fetal/maternal and ambulatory wellness monitoring systems
REDWOOD CITY, Calif., Mar. 06, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering…
Biotricity provides end of year shareholder update
REDWOOD CITY, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is providing an end of year…
Biotricity actively pursues Holter market with Bioflux product offering
REDWOOD CITY, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will…
Biotricity builds capacity with University of Calgary and receives ethics approvals for research
REDWOOD CITY, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the launch…
Distinguished physicians join Biotricity’s newly formed Scientific and Medical Alliance Board
REDWOOD CITY, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that Drs.…
Biotricity extends heart rate variability research to include fetal and maternal applications
REDWOOD CITY, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will…
Biotricity provides fiscal 2018 second quarter updates for shareholders
REDWOOD CITY, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today provided operational…
Biotricity developing ECG patch for anticipated Q1 2019 release
REDWOOD CITY, Calif., Sep. 05, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it is…
Biotricity issues statement regarding recent promotional activity
REDWOOD CITY, Calif., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), (the “Company”) announced today that it has been made aware of and requested by the OTC…
Biotricity expands salesforce to cover key US markets and begins advisory board expansion to move into preemptive heart disease diagnostics
REDWOOD CITY, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, has expanded its sales team…